D. L. Kirkpatrick, PhD, “In vitro and in vivo assessment of the abuse potential of PF614, a novel BIO-MD™ prodrug of oxycodone”, J of Opioid Management, vol. 13, no. 1, pp. 39–49, Jan. 2017.